The pharmaceutical market has always been highly competitive and subject to continuous innovations and new developments. To stay at the forefront of the market, the players always had to invest much in the development of new drugs and therapies. Today, they face a new challenge. ‘Connectivity’ and ‘Digital Health’ are new key-words in the industry. The SHL (Scandinavian Health LTD) Group, based in Nacka Strand, Sweden, is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery systems. ‘To make people’s life easier’ is the mission of the business. Nicholas Heaton, Executive Director Business Development Europe, is confi dent, that the company’s connected drug delivery solutions will set a new standard in the market and offer the patients an unprecendented level of convenience and easy handling.